AAAAAA

   
Results: 1-3 |
Results: 3
Nonpeptide endothelin antagonists in clinical development
Authors: Wu, CD Decker, ER Holland, GW Brown, PM Stavros, FD Brock, TA Dixon, RAF
Citation: Cd. Wu et al., Nonpeptide endothelin antagonists in clinical development, DRUGS TODAY, 37(7), 2001, pp. 441-453
Acyl substitution at the ortho position of anilides enhances oral bioavailability of thiophene sulfonamides: TBC3214, an ETA selective endothelin antagonist
Authors: Wu, CD Decker, ER Blok, N Li, J Bourgoyne, AR Bui, H Keller, KM Knowles, V Li, W Stavros, FD Holland, GW Brock, TA Dixon, RAF
Citation: Cd. Wu et al., Acyl substitution at the ortho position of anilides enhances oral bioavailability of thiophene sulfonamides: TBC3214, an ETA selective endothelin antagonist, J MED CHEM, 44(8), 2001, pp. 1211-1216
The discovery and structure-activity relationships of nonpeptide, low molecular weight antagonists selective for the endothelin ETB receptor
Authors: Chan, MF Kois, A Verner, EJ Raju, BG Castillo, RS Wu, CD Okun, I Stavros, FD Balaji, VN
Citation: Mf. Chan et al., The discovery and structure-activity relationships of nonpeptide, low molecular weight antagonists selective for the endothelin ETB receptor, BIO MED CH, 6(12), 1998, pp. 2301-2316
Risultati: 1-3 |